Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.98% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Consensus Cloud Solutions
CCSI
$716M
| $3.47M | 0.01% |
145,400
+13,700
| +10% | +$321K |
|
1677
Cricut
CRCT
$1.21B
| $3.47M | 0.01% |
608,543
+55,011
| +10% | +$330K |
|
1678
Allient
ALNT
$1.89B
| $3.46M | 0.01% |
142,472
-40,450
| -22% | -$892K |
|
|
TERN
1679
DELISTED
Terns Pharmaceuticals
TERN
| $3.45M | 0.01% |
623,134
+143,634
| +30% | +$973K |
|
1680
Celldex Therapeutics
CLDX
$3.29B
| $3.45M | 0.01% |
+136,588
| New | +$3.71M |
|
|
LPRO
1681
DELISTED
Open Lending Corp
LPRO
| $3.45M | 0.01% |
578,125
-42,800
| -7% | -$256K |
|
1682
Roundhill N-100 0DTE Covered Call Strategy ETF
QDTE
$963M
| $3.45M | 0.01% |
86,200
+26,900
| +45% | +$1.14M |
|
1683
T. Rowe Price
TROW
$23.6B
| $3.44M | 0.01% |
30,400
-173,300
| -85% | -$20.1M |
|
1684
Planet Labs
PL
$8.8B
| $3.44M | 0.01% |
850,600
+85,600
| +11% | +$266K |
|
1685
Security National Financial
SNFCA
$242M
| $3.44M | 0.01% |
314,881
-38,697
| -11% | -$390K |
|
1686
Organogenesis Holdings
ORGO
$230M
| $3.44M | 0.01% |
1,073,500
+255,600
| +31% | +$858K |
|
1687
AMC Global Media
AMCX
$510M
| $3.43M | 0.01% |
346,922
-138,258
| -28% | -$1.22M |
|
1688
Diebold Nixdorf
DBD
$2.48B
| $3.43M | 0.01% |
79,700
-48,700
| -38% | -$2.19M |
|
|
SAFE
1689
Safehold
SAFE
$1.08B
| $3.41M | 0.01% |
+184,762
| New | +$4.02M |
|
1690
Washington Trust Bancorp
WASH
$767M
| $3.41M | 0.01% |
108,668
+19,400
| +22% | +$673K |
|
|
THR
1691
DELISTED
Thermon Group Holdings
THR
| $3.41M | 0.01% |
118,362
-7,038
| -6% | -$207K |
|
1692
Global X S&P 500 Covered Call ETF
XYLD
$3.28B
| $3.4M | 0.01% |
81,070
-43,138
| -35% | -$1.81M |
|
|
PPLT
1693
abrdn Physical Platinum Shares ETF
PPLT
$2.04B
| $3.39M | 0.01% |
+408,730
| New | +$3.62M |
|
1694
Aviat Networks
AVNW
$287M
| $3.39M | 0.01% |
187,380
-20,294
| -10% | -$372K |
|
1695
TFI International
TFII
$12.1B
| $3.38M | 0.01% |
25,000
+11,100
| +80% | +$1.58M |
|
1696
Credit Acceptance
CACC
$6.1B
| $3.37M | 0.01% |
7,188
-3,000
| -29% | -$1.39M |
|
|
GAU
1697
Galiano Gold
GAU
$547M
| $3.37M | 0.01% |
2,741,253
+16,677
| +0.6% | +$24.1K |
|
1698
Hyliion Holdings
HYLN
$725M
| $3.37M | 0.01% |
1,290,566
+424,866
| +49% | +$1.18M |
|
1699
First United
FUNC
$293M
| $3.36M | 0.01% |
99,795
+1,200
| +1% | +$39.9K |
|
1700
Par Pacific Holdings
PARR
$4.02B
| $3.36M | 0.01% |
205,203
-185,631
| -47% | -$3.13M |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.